Weipu Mao1, Shaomin Wei2, Hui Yang3, Qianqian Yu4, Mei Xu1, Jing Guo4, Li Gao1. 1. Department of Obstetrics & Gynecology, The People's Hospital of Yingshang, Anhui 236200, PR China. 2. Department of Neurology, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, PR China. 3. Department of General Surgery, Jiuting Hospital, Songjiang District, Shanghai 201600, PR China. 4. Department of Obstetrics & Gynecology, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, PR China.
Abstract
Aim: Our aim was to analyze the clinicopathological features of lung, liver, bone and brain metastasis in patients with endometrial cancer (EC). Patients & methods: We screened patients diagnosed with EC between 2010 and 2015 from the Surveillance, Epidemiology and End Results database. Results: Among 69,027 eligible EC patients, lung metastasis was the most common. Patients with lung or liver metastasis were at higher risk of bone and brain metastases than those without lung and liver metastasis. Brain metastasis has the lowest survival time (5.0 months) in single organ metastasis. Liver and brain metastasis have the highest death rate in two organ metastasis, and lung, liver and brain metastasis had the lowest survival time (1.0 month) in multi-sites metastasis. Conclusion: Lung metastasis was the most common in EC patients. Assessing distant organ metastasis may help clinicians to determine appropriate follow-up strategy for patients with EC.
Aim: Our aim was to analyze the clinicopathological features of lung, liver, bone and brain metastasis in patients with endometrial cancer (EC). Patients & methods: We screened patients diagnosed with EC between 2010 and 2015 from the Surveillance, Epidemiology and End Results database. Results: Among 69,027 eligible ECpatients, lung metastasis was the most common. Patients with lung or liver metastasis were at higher risk of bone and brain metastases than those without lung and liver metastasis. Brain metastasis has the lowest survival time (5.0 months) in single organ metastasis. Liver and brain metastasis have the highest death rate in two organ metastasis, and lung, liver and brain metastasis had the lowest survival time (1.0 month) in multi-sites metastasis. Conclusion:Lung metastasis was the most common in ECpatients. Assessing distant organ metastasis may help clinicians to determine appropriate follow-up strategy for patients with EC.